Russell Investments Group’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $73.9K | Sell |
|
|||||
|
2025
Q2 | $469K | Sell |
|
|||||
|
2025
Q1 | $429K | Buy |
|
|||||
|
2024
Q4 | $207K | Sell |
|
|||||
|
2024
Q3 | $380K | Sell |
|
|||||
|
2024
Q2 | $428K | Buy |
|
|||||
|
2024
Q1 | $405K | Buy |
|
|||||
|
2023
Q4 | $326K | Sell |
|
|||||
|
2023
Q3 | $401K | Sell |
|
|||||
|
2023
Q2 | $555K | Sell |
|
|||||
|
2023
Q1 | $790K | Buy |
|
|||||
|
2022
Q4 | $816K | Buy |
|
|||||
|
2022
Q3 | $596K | Sell |
|
|||||
|
2022
Q2 | $598K | Sell |
|
|||||
|
2022
Q1 | $680K | Sell |
|
|||||
|
2021
Q4 | $1.24M | Buy |
|
|||||
|
2021
Q3 | $501K | Sell |
|
|||||
|
2021
Q2 | $1.19M | Sell |
|
|||||
|
2021
Q1 | $1.78M | Sell |
|
|||||
|
2020
Q4 | $1.83M | Sell |
|
|||||
|
2020
Q3 | $1.67M | Buy |
|
|||||
|
2020
Q2 | $2.02M | Buy |
|
|||||
|
2020
Q1 | $1.9M | Buy |
|
|||||
|
2019
Q4 | $243K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $634K | Sell |
|
|||||
|
2017
Q2 | $855K | Buy |
|
|||||
|
2017
Q1 | $541K | Hold |
|
|||||
|
2016
Q4 | $464K | Buy |
|